Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Jiang Su Yida Chemical Co.,Ltd (300721.SZ)
Jiangyin, CN
Jiang Su Yida Chemical Co.,Ltd, a company founded in 1996 and based in Jiangyin, China, specializes in manufacturing and supplying a comprehensive array of chemical products. Its primary offerings include both ethylene glycol ether and propylene glycol ether series, along with their various derivatives, catering to the Chinese market. Additionally, the company's product portfolio extends to encompass ethyl glyme, propyl glyme, braking fluid, polyethylene glycol, and diverse polyether compounds.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -0.23% | +5.39% | +49.37% | +36.02% | +37.86% | +67.32% | +30.43% | +36.54% | +19.60% | +68.25% | +68.25% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2024-11 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Chemicals - Specialty: +4.7%-10.0% Q1'26: +64.9% (vs Q1'25)
-
EPS growth Chemicals - Specialty: +13.2%-1,241.9% Q1'26: +111.9% (vs Q1'25)
-
FCF margin FCF growth · Chemicals - Specialty: +44.1%-2.0% Q1'26: +7.2% (vs Q1'25)
-
EBIT margin Chemicals - Specialty: +8.8%-7.6% Q1'26: +2.7% (vs Q1'25)
-
ROIC Chemicals - Specialty: +5.6%-6.0% Q1'26: +1.8% (vs Q1'25)
-
Share dilution Chemicals - Specialty: +0.1%-0.1% Q1'26: 0.0% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Chemicals - Specialty: 0.18×16.56× Q1'26: 19.31× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2023 actual |
Dec 2024 actual |
|---|---|---|---|---|---|---|
| Revenue |
1.00B
est: 1.07B (-6.2%)
|
1.93B
est.
|
1.45B
est: 1.58B (-7.9%)
|
1.55B
est: 3.04B (-48.9%)
|
1.81B
est: 3.04B (-40.4%)
|
1.77B
est: 3.54B (-50.1%)
|
| EBITDA |
67.98M
est: 115.58M (-41.2%)
|
208.10M
est.
|
240.20M
est: 170.13M (+41.2%)
|
224.41M
est: 328.82M (-31.8%)
|
127.53M
est: 328.82M (-61.2%)
|
150.82M
est: 360.01M (-58.1%)
|
| EBIT |
16.20M
est: 53.59M (-69.8%)
|
96.48M
est.
|
186.04M
est: 78.88M (+135.9%)
|
157.63M
est: 152.45M (+3.4%)
|
-24.53M
est: 152.45M (-116.1%)
|
39.32M
est: 114.81M (-65.8%)
|
| Net Income |
-3.88M
est: -1.74M (-123.7%)
|
415.59M
est.
|
131.84M
est: 147.49M (-10.6%)
|
109.58M
est: 334.03M (-67.2%)
|
-35.29M
est: 334.03M (-110.6%)
|
9.53M
est: 414.72M (-97.7%)
|
| SGA |
51.61M
est: 49.84M (+3.6%)
|
89.74M
est.
|
78.48M
est: 73.37M (+7.0%)
|
90.52M
est: 141.79M (-36.2%)
|
197.31M
est: 141.79M (+39.2%)
|
124.24M
est: 239.60M (-48.1%)
|
| EPS |
-0.03
est: -0.01 (-149.9%)
|
2.52
est.
|
0.82
est: 0.89 (-8.4%)
|
0.68
est: 2.03 (-66.4%)
|
-0.24
est: 2.03 (-111.8%)
|
0.06
est: 2.52 (-97.7%)
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-12 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-11 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-08 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-07 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-06 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-30 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-29 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-28 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-27 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-24 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-23 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-22 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-21 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-20 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-17 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-16 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
This company is not held by any ETF in our universe.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Feng Liu | Deputy GM, Secretary to the Board & Director | — | male |
| Gang Xu | Deputy General Manager | — | male |
| Meng Liu | Deputy General Manager | — | male |
| Wenlin Hu | Deputy General Manager | — | male |
| Xiangying Leng | Deputy General Manager | — | male |
| Xun Wu | Deputy General Manager | — | female |
| Yin Fen Sun | Chief Financial Officer and Director | — | female |
| Yingjun Li | Deputy General Manager | — | male |
| Yong Liu | Deputy General Manager | — | male |
| Zhun Liu | Chairman of the Board & GM | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 300721.SZ
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
